Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,376 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents.
Axelrad J, Bernheim O, Colombel JF, Malerba S, Ananthakrishnan A, Yajnik V, Hoffman G, Agrawal M, Lukin D, Desai A, McEachern E, Bosworth B, Scherl E, Reyes A, Zaidi H, Mudireddy P, DiCaprio D, Sultan K, Korelitz B, Wang E, Williams R, Chen L, Katz S, Itzkowitz S; New York Crohn's and Colitis Organization. Axelrad J, et al. Among authors: katz s. Clin Gastroenterol Hepatol. 2016 Jan;14(1):58-64. doi: 10.1016/j.cgh.2015.07.037. Epub 2015 Aug 3. Clin Gastroenterol Hepatol. 2016. PMID: 26247164
Hyperamylasemia in inflammatory bowel disease.
Katz S, Bank S, Greenberg RE, Lendvai S, Lesser M, Napolitano B. Katz S, et al. J Clin Gastroenterol. 1988 Dec;10(6):627-30. doi: 10.1097/00004836-198812000-00010. J Clin Gastroenterol. 1988. PMID: 2466072
Pulmonary manifestations of inflammatory bowel disease.
Storch I, Sachar D, Katz S. Storch I, et al. Among authors: katz s. Inflamm Bowel Dis. 2003 Mar;9(2):104-15. doi: 10.1097/00054725-200303000-00004. Inflamm Bowel Dis. 2003. PMID: 12769444 Review.
Small bowel adenocarcinoma in Crohn's disease.
Feldstein RC, Sood S, Katz S. Feldstein RC, et al. Among authors: katz s. Inflamm Bowel Dis. 2008 Aug;14(8):1154-7. doi: 10.1002/ibd.20393. Inflamm Bowel Dis. 2008. PMID: 18275076 Review.
A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease.
Sandborn WJ, Feagan BG, Fedorak RN, Scherl E, Fleisher MR, Katz S, Johanns J, Blank M, Rutgeerts P; Ustekinumab Crohn's Disease Study Group. Sandborn WJ, et al. Among authors: katz s. Gastroenterology. 2008 Oct;135(4):1130-41. doi: 10.1053/j.gastro.2008.07.014. Epub 2008 Jul 17. Gastroenterology. 2008. PMID: 18706417 Clinical Trial.
3,376 results